Vertebroplasty and Kyphoplasty Market Size

Vertebroplasty & Kyphoplasty Market Analysis

The vertebroplasty and kyphoplasty market is expected to register a CAGR of 5.1% over the forecast period.

The COVID-19 pandemic impacted the vertebroplasty and kyphoplasty market in the early phase due to the worldwide implementation of stringent lockdowns. Additionally, hospital admissions for patients other than COVID-19 and serious diseases were restricted to enter hospitals to avoid the spread of the virus. For instance, according to the study published in SAGE Journals in April 2022, there have been noticeable changes in the hospital admissions of patients with vertebral compression fractures (VCF) compared to the period before the Covid-19 pandemic. Fewer patients visited the emergency department for VCF during the peak of the Covid-19 pandemic which represented a 44% decrease. Hence, COVID-19 affected the pace of the market at the beginning of the pandemic. However, currently, the COVID cases declined and healthcare services are resumed, the market is expected to gain traction and project stable growth over the next 3-4 years

The rising population of osteoporosis, rising geriatric population, and technological advancements in the products, increasing burden of vertebral compression fractures are driving the growth of the studied market.

Aging is the primary factor driving the market growth for the treatment. According to the United Nations Department of Economics and Social 2022 report, there were 771 million people aged 65 years or over globally in 2022 and the older population is projected to reach 994 million by 2030 and 1.6 billion by 2050. Thus, the demand for vertebroplasty and kyphoplasty is expected to rise with the growing geriatric population due to the loss of bone mass that occurs as part of aging in the elderly.

The research article published by Frontiers in Endocrinology Journal in May 2022, stated that about 200 million women suffer from osteoporosis worldwide. It was projected that by 2050, the worldwide incidence of hip fracture would increase by 310% in men and 240% in women. The same article indicated that almost all types of fractures increase in patients with low bone mineral density and adults who already have one type of fracture are 50% to 100% more likely to have a different type of fracture, regardless of the type. This highlights that fracture is the most serious complication of osteoporosis and the increasing prevalence of osteoporosis will ultimately boost the vertebroplasty and kyphoplasty market growth.

Additionally, the advancements in technology and increasing product approvals, and launches, along with partnerships and collaborations by key players are helping in the market growth. For instance, in August 2021, IZI Medical launched Vertefix HV Cement, a product that aims to address the need for flow visualisation during cement injection for vertebroplasty and kyphoplasty procedures. Hence, such launches are expected to boost the demand for vertebroplasty and kyphoplasty procedures, thereby leading to increased adoption of the devices, and driving market growth.

Therefore, owing to the aforementioned factors such as the rising prevalence of osteoporosis, the rising elderly population, technological advancements in vertebroplasty and kyphoplasty products is anticipated to witness growth over the analysis period. However, a stringent regulatory framework related to vertebroplasty and kyphoplasty is likely to impede the market growth.